← Browse by Condition
Medical Condition
carcinoma squamous cell
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2
NCT04481256
Recruiting
TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY
Enrollment
49 pts
Location
Netherlands
Sponsor
Academisch Medisch Centrum - U...
NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Enrollment
292 pts
Location
United States, Austr...
Sponsor
Bicara Therapeutics
NCT06669572 Phase 2
Recruiting
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
Enrollment
35 pts
Location
United States
Sponsor
University of Chicago
NCT05252078 Phase 2
Recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
Enrollment
30 pts
Location
China
Sponsor
Jiangxi Provincial Cancer Hosp...